Differential efficacy of bortezomib plus chemotherapy within molecular subtypes of diffuse large B-cell lymphoma

Gene expression profiling of diffuse large B-cell lymphoma (DLBCL) has revealed distinct molecular subtypes that include germinal center B cell–like (GCB) and activated B cell–like (ABC) DLBCL. ABC DLBCL has a worse survival after upfront chemotherapy and is characterized by constitutive activation...

Full beskrivning

Sparad:
Bibliografiska uppgifter
Huvudupphovsmän: Dunleavy, Kieron, Pittaluga, Stefania, Czuczman, Myron S., Dave, Sandeep S., Wright, George, Grant, Nicole, Shovlin, Margaret, Jaffe, Elaine S., Janik, John E., Staudt, Louis M., Wilson, Wyndham H.
Materialtyp: Artigo
Språk:Inglês
Publicerad: American Society of Hematology 2009
Ämnen:
Clinical Trials and Observations
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC2699229/
https://ncbi.nlm.nih.gov/pubmed/19380866
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2009-01-199679
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk